Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer.
J Clin Endocrinol Metab. 2012 Sep;97(9):3179-84. doi: 10.1210/jc.2012-1520. Epub 2012 Jul 6.
J Clin Endocrinol Metab. 2012.
PMID: 22774206
Free PMC article.
Clinical Trial.
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.
Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Sideras K, Morris JC 3rd, McIver B, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Goh BC, Tang H, Ivy SP, Erlichman C; Endocrine Malignancies Disease Oriented Group; Mayo Clinic Cancer Center; Mayo Phase 2 Consortium.
Bible KC, et al. Among authors: webster kp.
Lancet Oncol. 2010 Oct;11(10):962-72. doi: 10.1016/S1470-2045(10)70203-5. Epub 2010 Sep 17.
Lancet Oncol. 2010.
PMID: 20851682
Free PMC article.
Clinical Trial.
Item in Clipboard
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.
Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Karlin N, Sideras K, Morris JC 3rd, McIver B, Hay I, Fatourechi V, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Cher Goh B, Isham CR, Harris P, Erlichman C; Endocrine Malignancies Disease Oriented Group, Mayo Clinic Cancer Center, and the Mayo Phase 2 Consortium.
Bible KC, et al. Among authors: webster kp.
J Clin Endocrinol Metab. 2014 May;99(5):1687-93. doi: 10.1210/jc.2013-3713. Epub 2014 Feb 25.
J Clin Endocrinol Metab. 2014.
PMID: 24606083
Free PMC article.
Clinical Trial.
Item in Clipboard
Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway.
Thress K, Macintyre T, Wang H, Whitston D, Liu ZY, Hoffmann E, Wang T, Brown JL, Webster K, Omer C, Zage PE, Zeng L, Zweidler-McKay PA.
Thress K, et al.
Mol Cancer Ther. 2009 Jul;8(7):1818-27. doi: 10.1158/1535-7163.MCT-09-0036. Epub 2009 Jun 9.
Mol Cancer Ther. 2009.
PMID: 19509272
Item in Clipboard
Payoff time: successful coalition building.
Webster KP.
Webster KP.
Fla Nurse. 1988 Nov-Dec;36(10):3.
Fla Nurse. 1988.
PMID: 3203815
No abstract available.
Item in Clipboard
FNA's President message. "No system can endure that does not march and march we must, or retreat we shall".
Webster KP.
Webster KP.
Fla Nurse. 1988 Oct;36(9):1, 3, 5.
Fla Nurse. 1988.
PMID: 3197864
No abstract available.
Item in Clipboard
A day in the life of a home health nurse.
Webster KP.
Webster KP.
Fla Nurse. 1982 Feb;30(2):1-4.
Fla Nurse. 1982.
PMID: 6918328
No abstract available.
Item in Clipboard
Planning and implementing health screening programs.
Webster KP.
Webster KP.
J Sch Health. 1980 Nov;50(9):493-5. doi: 10.1111/j.1746-1561.1980.tb02071.x.
J Sch Health. 1980.
PMID: 6905891
No abstract available.
Item in Clipboard
Cite
Cite